Guerrero Ramiro's Form 4 filing
MAIA Biotechnology, Inc. (MAIA) · filed Sep 13, 2022
- Accession no.
- 0001127602-22-022401
- Filed
- Sep 13, 2022
- Trade date
- Sep 13, 2022
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market purchases total $33.9K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Guerrero RamiroCIK 0001913253 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 13, 2022 | Common Stock | PPurchaseAcquired | +8,798.73 | $3.85F1 | +$33,875.11 | 297,464.04 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
These shares were purchased by the reporting person in the open market for $3.85 per share on September 13, 2022.
Referenced by the price of 1 transaction in Table I.